Beijing Biostar Pharmaceuticals Co., Ltd.
Beijing Biostar Pharmaceuticals Co., Ltd., commonly referred to as Biostar, is a prominent player in the biopharmaceutical industry, headquartered in Beijing, China. Founded in 2000, the company has established itself as a leader in the development and manufacturing of innovative pharmaceutical products, particularly in the fields of oncology and infectious diseases. Biostar's core offerings include a range of high-quality generic drugs and proprietary formulations, distinguished by their efficacy and safety profiles. The company has achieved significant milestones, including various certifications and partnerships that enhance its market position. With a strong focus on research and development, Biostar continues to expand its operational reach across Asia and beyond, solidifying its reputation as a trusted provider in the global healthcare landscape.
DitchCarbon Score
How does Beijing Biostar Pharmaceuticals Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Biostar Pharmaceuticals Co., Ltd.'s score of 15 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Biostar Pharmaceuticals Co., Ltd.'s reported carbon emissions
Beijing Biostar Pharmaceuticals Co., Ltd., headquartered in CN, currently does not have available data on carbon emissions or specific climate commitments. There are no reported emissions figures, including Scope 1, 2, or 3 emissions, nor any established reduction targets or initiatives. This absence of data suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly prioritises sustainability, it will be essential for Beijing Biostar Pharmaceuticals to establish clear climate commitments and reduction targets to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Biostar Pharmaceuticals Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
